Posted on July 21st, 2016 by msequeira
Cosette Wheeler, PhD, led an international team that studied the efficacy of the human papillomavirus (HPV) vaccine in women 26 years and older. The United States currently targets girls and boys in their early teen years to receive the vaccine. Information on the vaccine's efficacy in women older than the target age range had not been collected before.
The new research, published in The Lancet Infectious Diseases, shows that the vaccine helps to prevent HPV-related infections and cancers.
Dr. Wheeler talks about the research on "KRQE This Morning"
And she talks to Mike Jaxson, KSVP-AM:
You must be logged-in to the site to post a comment.